WO2016126793A1 - Apparatus and method for skin treatment using continuous light - Google Patents

Apparatus and method for skin treatment using continuous light Download PDF

Info

Publication number
WO2016126793A1
WO2016126793A1 PCT/US2016/016329 US2016016329W WO2016126793A1 WO 2016126793 A1 WO2016126793 A1 WO 2016126793A1 US 2016016329 W US2016016329 W US 2016016329W WO 2016126793 A1 WO2016126793 A1 WO 2016126793A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
electromagnetic energy
user
region
light
Prior art date
Application number
PCT/US2016/016329
Other languages
French (fr)
Inventor
Iranpour Khormaei
Lilac Muller
James Christopher MCINNES
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Priority to KR1020177021793A priority Critical patent/KR102132417B1/en
Priority to EP16747171.3A priority patent/EP3240609B1/en
Priority to CN201680008650.8A priority patent/CN107206250B/en
Priority to JP2017540701A priority patent/JP7040942B2/en
Priority to BR112017014275A priority patent/BR112017014275A2/en
Publication of WO2016126793A1 publication Critical patent/WO2016126793A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0616Skin treatment other than tanning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0092Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying media, e.g. remedies, on the human body
    • A61M35/003Portable hand-held applicators having means for dispensing or spreading integral media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00137Details of operation mode
    • A61B2017/00154Details of operation mode pulsed
    • A61B2017/00172Pulse trains, bursts, intermittent continuous operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • A61B2018/00458Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/0091Handpieces of the surgical instrument or device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B2018/1807Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using light other than laser radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0644Handheld applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes
    • A61N2005/0652Arrays of diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light
    • A61N2005/0663Coloured light

Definitions

  • the disclosure generally relates to m apparatus ami method for skin treatm n which Incl udes applying skin formulations, typically to the skin area, which operate i the sonic frequency range, in. combination wi th electromagnetic radiation to the skin ares.
  • an apparatus including an applicator assembly thai includes an applicator tip which is configured to apply a cyclical mechanical force to a skin surface area of a user and to deliver a. skin formulation- to a skin surface area of a user.
  • the cyclical mechanical force includes a normal component.
  • the cyclical mechanical force includes a shear component
  • the cyclical mechanical force includes and normal component and a shear component.
  • the applicator tip is configured to apply a normal stress and a shear stress to a region of skin.
  • the apparatus further includes an electromagnetic energy assembly that includes at least one -electromagnetic energ sourc adjacent to or within, the applicator assembly and configured to deliver a continuous electromagnetic energy stimulus of a character and for a dar tion sufficient to penetrate one or more dermal layers within, the skin surface area of a user.
  • factors that affect penetration depth of electromagnetic energy in tissue include wavelength, frequency, intensity, duration, and the like.
  • electromagnetic energy sources i include electromagnetic energy emitters, fiber lasers, laser diodes, lasers, light-emitting diodes, mier cavity light- emitting diodes, organic Rght-em ng diodes, polymer ligto-etraitiag diodes, quaaiuffl dots, idtni-fest lasers, and the like.
  • the at least one electromagnetic energy source is adjacent to an outer edge of the applicator assembly.
  • the at leas one electromagnetic energy source comprises a plurality of light-enriiting diodes and is configured to concurrently or sequentially generate at least a first continuous electromagnetic energy stimulus having a peak emiss ive wavelength of abou t 5:90 nanometers and a second continu us electromaguetic exiergy stimulus having a peak emissive wavelength ranging from, about 850 nanometers to about 870 nanometers,
  • the at least one electromagnetic energy source is configured to produce a single dominant emissive wavelength via narrowband
  • the single dominant emissive wavelength is about 590 ran.
  • the at least on electromagnetic energy source includes at least one light emitting diode (LED),
  • the at least one LED includes a first LED which emits tight at a dominant, emissive wavelength: -of about 590 am and a second LED which emits light at about 850-870 nm.
  • the fi st LED emits visible yellow light and the second LED emits infrared light.
  • a ratio of power radiatio of th first LED to the second LED is 4: 1.
  • the first LED emits. Sight at about 4 milliwatts per square centimeter ( W/enr) and th second LED emits light a a out 1 mW cm 2 ,
  • an energy uenee of the electromagnetic energy assembly received at the skin, surface area is less than about 4 J/cm 2 ,
  • the electromagnetic, energy assembly further comprises
  • a hood configured to limit an interrogation region on. the skin .
  • the electromagnetic energy assembly further includes a lens configured to focus electromagnetic energy stimulus: emitted from the electromagnetic energy assembly to limit a» interrogation region oft the: skin.
  • the at least one electromagnetic energy source ncludes a ⁇ plurality of electromagnetic energy sources which surround (he applicator assembly.
  • the electromagnetic energy assembly further comprises
  • the at least one electromagnetic energy source is included within the applicator assembl .
  • a method of skin treatment is provided, iffipiemented b a skin treatment apparatus, that includes applying a cyclical mechanical force to a skin surface area of a user of a character and for a dur tion sufficient to cause a compressive force on the skin surface area of a user and to affect the permeability of a skin formulation.
  • the method further in cludes interrogating the skin, surface area of the user with, a con tinuous electromagnetic energy stimulus of a character and for duration sufficient to penetrate one or more dermal layers within the skin .surface area of a user.
  • a method of skin treatment is provided, implemented by a skin treatment: apparatus, thai includes applying a cyclical mechanic l force to a skin surface area of a user of a character and for a dura ion sufficient to cause a compressi ve force and a shear force on the skin surface area, of a use and to affect the peraieahility of a skin formulation.
  • the method includes applying the .cyclical, mechanical force to the skin surface area of a user of a character and for a duration sufficient to cause a compressive force on the skin surface area of a user -and to affect the permeability of a skin, formulation includes applying a substantially normal oscillating force to the skin surface area, f0023
  • the method includes applying the cyclical mechanical force to the skin surface area of a use of a character and for a duration -sufficient to cause a compressive force on the skin surface are of a user and to affect the permeability of a skin formulation includes applying an normal mechanical force having an amplitude of .motion perpendicular to the surface of the skin ranging from about 0,01 inches to about 0.075 inches.
  • the method includes interrogating the skin surface area of the user with the continuous electromagnetic energy stimulus of a character and for a duratio sufficient to penetrate at least one or more dermal layers within the skin surface area of a user includes concurrently or sequentially emitting at least a first continuous
  • electromagnetic energy stimulus having a peak -emissive wavelength of about 590 nanometers and a second . ' continuous electromagnetic energy stimulus having a peak emissive wavelength ranging from about 830 nanometers to about 870 nanometers,
  • the method includes interroga ing the skin surface area of the user with the continuous eleeiromsgnede energy stimulus of a character and for a duration sufficient to penetrate at least one or more dermal layers within the- skin surface area of a user includes concurrentl or sequentially emitting at least a first continuous
  • electromagnetic interrogation Stimulus having peak kradiance of about 4 milliwatts per square centimeter (mW/cm 2 ) and emitting a second continuous electromagnetic ntterrogation stimulus having a peak, irradianee/at about 1 m /cruA
  • an electromagnetic energy assembly includes at least one electromagnetic energy source adjacent to or thiri the. applicator assembly and configured to deliver a continuous electromagnetic energy stimulus of a character and for a duration sufficient io penetrate one or more dermal, layers within the ski surface area of a user and to affect ⁇ regulation of one or more epidermis-associated proteins,
  • an electromagnetic energy assembly includes at least one electromagnetic energy source adjacent to or within the applicator assembly and configured to deliver a continuous electromagnetic energy stimulus of a character and for a duration sufficient to penetrate one or more dermal layers within the skin surface are of a rjser and to affect tipregniation of one or more epidermal proteins selected from the group consisting of filagrin; transglutaminase 1 (TOO); glycoprotein (CD44); keratin 10 ( J9); keratin 1 ( 1.4); tenacin C; globular aciin ' (ActinG); fibrillar ⁇ actin (AeiinF) and syndecan 1.
  • an electromagnetic energy assembly includes at least one- electromagnetic energy source adjacent to or within the applicator assembly and configured to deli ver a continuous ' electromagnetic energy stimulus of a character and for a duration sufficient to penetrate one or more dermal layers within the skin surface area of a user and to affect upregulaiio of one or more derenoepidermai.
  • junction proteins selected from. the. group consisting of collagen 4 (Coil 4); collagen 7 (Coll. 7); lamiuin V; and perleeaa.
  • an electromagnetic energy assembly includes at least, one electromagnetic energy source adjacent to or within the applicator assembly and configured ⁇ deliver a continuous electromagnetic energy stimulus of a character and for a dardtion sufficient to penetrate one or .more dermal layers within, the skin surface area of a user and to affect ⁇ regul ion of one or more dermal proteins selected from the group consisting of hyaluronati synthase 3 (HA$3); fibronectra; tropoeJastin; . procolli ; integrin; and decorift.
  • HA$3 hyaluronati synthase 3
  • Fig. I illustrates an applicator apparatus according to an embodiment
  • Figs. 2A ? 2B, 2C, and 2D illustrate a sequence of a desired motion of an applicator tip of the applicator apparatus.
  • Fig. 5 is a cross-sectional diagram showing the overall operating parts contained within die applicato apparatus.
  • Fig, 4 illustrates a first vie of the motor and its related components of the applicator apparatus.
  • Fig. 6 ' illustrates a third view of the motor and its related components of the applicator apparatus.
  • ⁇ 99371 F s» 7A, 70, 7C, a».d 7D illustrate a .method of installing a lighting unit into a housing of the applicator apparatus.
  • 0038J Fig. 8 shows a block diagram of hardware om one ts ' used in conjunction with the LED assembly.
  • 06391 Bgs. 9A and 9B illustrate details of the individual lighting- units contained in the LED assembly
  • ⁇ 00401 Fig. 1.0 illustrates an embodiment of the applicator apparatus which includes a hood.
  • ⁇ I J Fig. 1 i illustrates an embodiment of the applicator apparatus which Mffles a lens.
  • f0 421 Fig, 12 illustrates a particular method of using the applicator apparatus,
  • Figs, 14A and 14B illustrate an embodiment in which a plurality of light assemblies surround the applicator tip.
  • Figs. ISA and 15B illustrate an embodiment in which a light assembly is included within the applicator tip.
  • Fig, 16 illustrates an embodiment of a process performed by the applicator apparatus
  • FIG. 1 shows an applicator appliance, is which one or more methodologies or technologies can be ⁇ . implemented such as, for example, concurrently or sequentially
  • an applicator appliance includes a body portion 12, which is separate from a ca portion (not shown). Extending from the u er surface IS of bod portion 12 is an applicator tip 20 which contacts the skin of the user.
  • the applicator ti 20 comprises one or more elastomeric materials. In an embodiment the applicator ti 2.0 comprises one or more polymeric materials. In an embodiment, the applicator tip 20 is formed from silicone. In an embodiment, the applicator tip 20 is formed- from super soft silicone having a shore 00-30 hardness. Further non-limiting examples of applicator tip materials include ethylene propylene dhari rubbers,
  • the applicator tip 20 comprises one or more waveguides operahiy coupled to at least one electromagnetic energy emitter.
  • the applicator ti 20 comprises on or more transparent, translucent, or ligh transmitting materials...
  • the applicator tip 20 comprises one or more optically clear materials, semi-clear materials, plastics, thermo piastics, polymers, resins, thermal resins, and die like. I « an embodiment, the applicator tip 20 comprises one or more ofaceiaJ.
  • copolymers acrylic, glass, Ag.Br, AgCt ⁇ 1 ⁇ 20 3 ⁇ 4 , GeAsSe glass, .BaF 2i Gaf CdTe,: AsSeXe glass, Csi, -diamond, GaAs, Ge, ITRAN materials, Br, thallium bromide-Iodide, LiF, Mg.F ; , NaO > polyethylene, Pyres., Si , Si(3 ⁇ 4, ZnS, XnSe, thermoplastic polymers, thermoset
  • examples of op tically transparent, translucent, or iighi- transmitting materials include one or more of acrylonitrile butadaine slyrene polymers, celiulosic, epoxy; ethylene butyl aerylate, ethylene tetrafluoroethylene, ethylene vinyl
  • poiyeiliersitlforie . polyethylene, oiyimide, qlymethyl methaerylaie, polynorboniene, polypertluoroalkoxyetbykhe,. polystyrene, poiysu!fone, po!yurethane, polyvinyl chloride, polyvinylideue fluoride, diaMyl phthalate, thermoplastic elastomer, transparent polymers, vinyl esters, and the like.
  • the applicator tip 20 is configured to. deli ver continuous electromagnetic energy stimulus of a character and fo a duration sufficient to penetrate -one or more dermal layers within the skin sur&ee area of a user.
  • the applicator tip 20 comprises an optically transparent * translucent, or light-transmitting materials; is operably coupled to one or more electromagnetic energy emitters; and is configured to generate a continuous electromagnetic energy stimulu of a character and for a duration sufficient to penetrate one or more dermal layers within the skin surface area of a user, in an mibodinient, factors thai affect penetration depth of electromagnetic energy in tissue include wavelength, frequency, intensity, duration, and the like.
  • applicator tip 20 includes a concave portion 22 at a orward end thereof.
  • the concave portion will temporarily hold a selected, quantity of a skin limita ion which, is to be applied to the iter' facial, skin area daring operation of the appliance.
  • Included, in the u er ' surface ' 18 is a»..L.ED light assefnbly 100, the instaHatioft o which will be described in mo e detail later in this document.
  • the appliance is controlled by an on/off switch (not shown).
  • a complex motion of the applicator tip 20 has been found to be important
  • a first component of the app licator tip motion is perpendicu l ar to the sur face of tire skin, a second componen of motion is parallel to the surface of the skin, and a third component is arcuate which results, in progressively increasing contact between the applicator tip and the skin.
  • FIG. 2 shows a sequence of this desired motion.
  • tO (FIG. 2 A)
  • initial contact between applicator tip 20 and skin area 1 is shown.
  • the inside edge 2 OA o f the applicator tip 20 comes first into contact with the surface of the skin 21.
  • Force is beginning to be applied downwardly, perpendicular to the surface of the skin, producing an initial amoun of compressive force on the skin.
  • Initial tensile stress is also produced on the skin 21.
  • S applicator dp 20 is rotating clockwise as well as moving downwardly
  • the applicator tip motion changes at time 12 (FIG. 2C), and again at time B (FIG. 2 ) S at whic point the contacting surface of the applicator tip is essentially parallel to the surface of the skin 21 with the contacting surface of the applicator tip in full contact with the skin, and wltk both the compressive force perpendicular to the ski and. th tensile stress parallel to the surface of the skin reaching a maximum value.
  • the applicator tip produces a compressive force against the s kin along the entire contacting surface of the applicator tip, as shown in FIG. 2D,
  • the motion -of the applicator ti then is reversed by motor action, with the applicator rip ending up at its initial position.
  • the sequence 2A-2D is then repeated, at a selected frequency.
  • the above described motion while complex, has the dual advantage of producing effective absorption, of the skin formulation as well as maintaining a satisfactory comfortable level of contact for the user, such that the average user will continue to use the applicator.
  • the complex motion combined with the concave shape of the forward surface of the applicator tip, helps to keep the quantity o ski formulation present in me concave portion from being immediately displaced from th area of application on the user's skin.
  • FIG. 3 is a cross-sectional diagram showing the overall operating parts contained within the appliance body 12,
  • the appliance body 12 includes a motor referred to generally at 30, which will he described in..more detail below, and a source of po was, which in the embodiment shown are rechargeable batteries 32, but which could be other power sources as well, such as primary cells or an external power supply.
  • the control, signal to th motor as
  • Microprocessor 34 is conventional in structure and operation for such n a liance. All of the above parts are contained within housing portion
  • FIGS, 4-6 show the motor 30 for the appliance. in. more detail.
  • the motor inclodes an anchor member 36 which is made from a stiff material: which, in the embodiment shown, is bard plastic.
  • the anchor member i the embodiment shown, includes two slots 40 and 42 ' hich- are at right angles to each other, and which fit securely into corresponding rib elements 44 and 46 which are n of the boosing portion 1 (FIG. 3).
  • the anchor member 36 is thus fixed in position in the housing and is not free to move during operation of the motor.
  • Motor 30 also includes an armature assembly 48 which includes two spaced permanent magnets 50 and 52 mounted, on a metal baekiron 51 (FIGS. 3, ).
  • the permanent magnets are spaced approximately 0.18 inches apart, but this can be varied. Further, the permanent magnets, in the embodiment shown, are 0.15 inches square by 0, 1 inches thick, ' although these dimensions can also vary.
  • a t one end 53 of the armature member 48 is a removable applicator tip assembly 56, at the forward end of which is positioned applicator ti .20.
  • the applicator tip 20 is described in more detail in co-pending U.S, patent application Ser. No. 12/474,426, owned by th assignee of the present disclosure, the contents of which are hereby incorporated by reference.
  • the applicator tip has a concave forward surface, to hold the skin formulation and is made from a very soft material, Shore scale OO Durometer 30. The flexibility of the material is similar to that of human skis and thus transmits motion and force efficiently.
  • ⁇ 00641 Positioned between anchor member 36 and armature . 8 is a electromagnetic stator assembly 60.
  • the electromagnetic stator assembly 60 includes a conventional electromagnet 6.1 and an E-core laminated stack 62, the outer legs of which, m separated from the center leg ' by 0.257 inche and 0.267 inches,, respectively, in. th embodiment shown.
  • the stator pole are the ends of th three legs.
  • the siator assembly Is mou n ted to two opposing ribs 64 and 66 whi ch are also pari of hous i ng portion 16» Hence, in operation of the motor the stator assembly 60 also remains fixed irs position.
  • the motor further includes two l eaf springs 8 ' and 70 which extend between and connect anchor member 36 and opposing extending en portions 53 and 55 of ' armature 48.
  • 0i66J The extending end portions of armature 48 are at right angles to each other.
  • the leaf springs are approximately 0.2 inches wide and.0,012 inches thick and are made of stainless steel
  • the leaf springs 68 and 70 also extend approximately at .right angles to each other.
  • Leaf springs 68 and 70. have different free lengths. The ratio of the free lengths of the leaf springs is important to achieve the desired rmtlii-component motion of the. applicator tip to produce effective and comfortable application of skin formulations. The rati of the length of.
  • spring 70 to the length of spring 68 is within the range of 0.75: i to 0,95: 1 , In an embodiment, the tree length ratio is within the range of 0,79: 1 to 0.S3 : 1 , When the appliance is properly oriented relative t the skin, leaf spring 68 ill be approximately perpendicular to the skin, while leaf spring 70 will he approximately parallel wi th the skin . It is this arrangement of leaf springs, which produces the desired combination of effective absorption of skin formulation and com&rt to the user,
  • an alternating current electrical signal from microprocessor 34 is rovide to the electromagnetic stator assembly 60.
  • the two outer poles of the electromagnet will attract one of the permanent magnets and repel the other permanent magnet
  • the center pole will also repel one permanent, magnet while attracting the other.
  • the resulting force moves -armature 48:, including the applicator tip, in a complex slightly arcuate motion counterclockwise (as viewed in FIG. 5) relative to the stator assembly 60 and toward the skin.
  • This motion as indicated above, a d. as shown, in FIG . 2A-2D, includes a
  • the frequency of the action is typically within a range of 50-200 Hz.
  • the .frequency of the action ranges from, about of 110 Hz "to about 135 ⁇ .
  • the range of amplitude ' of the motion, perpendicular to the surface of the skin j$ within the range of 0.01 inches to 0.075 inches, in an embodiment., the range ofamplita.de of the motion perpendicular to the surface of the skin ranges if a m about 0.02 inches to about 0.035 inches.
  • the range of motio parallel, to the surface of the skin is within the range of 0.005 inches to 0.07 inches.
  • the range of motion parallel to the surface of ihe skin ranges from about 0,013 inches to about 0.032 inches.
  • the arcuate- motion that results from these dimensions is relatively small, following a» arc in the range of 0.5°-3°. in an embodiment, the arcuate motion thai results from these dimensions is about 2 although this value will vary with the actual dimensions used.
  • leaf springs 68 and 70 act to both center fee armature when i t is at rest and to produce a mechanicall resonant system when combined with the mass of the moving armature and the applicator tip assembly.
  • the electrical current alternates direction at a frequency - roughly equal to the mechanical resonance of the overall system, the amplitude of motion of the armature structure increases significantly, thus producing the required motion for effective action with the desired high efficiency relative to the electrical power input.
  • the appliance is both effective in producin rapid and effective absorpiioa of the skin formulation, but also is a practical appliance to operate.
  • the above-described structure further includes single -or multiple light sources, to produce either a single dominant-emissive wavelength, i.e., la ' narrowband maUichromatie radiation, or multiple wavelengths (either monochromatic, narrowband midilehroma ic, wideband muitichromatie, or combinations -thereof).
  • the single or multiple combinations m be applied either simultaneously or sequentially,
  • embodiment of the present disclosure may use LEDs, ultrasound and/or laser or light energy, the present disclosure is not limited to the use of these energy sources.
  • Other sources of energy including (without limitation) microwave energy and radio frequency energy may also he used.
  • Exemplary of -known light so rces are uoreseent lights, fiash!anips, filamentous lights, etc.
  • any light source capable of emitting electromagnetic radiation at a medically useful wa velength, as described herein, directly, or by means of optical filtration is within the scope of suitable light sources according to the present disclosure.
  • any source capable of emitting light havin a wavelength from about 300 »m to about 1 00 am, or producing electromagnetic radiation which is filtered or otherwise altered to exposure the skin, a topical composition, or -other component of the present treatmen t regime to a wavelength of light in the aforementioned range is medically useful.
  • the targeted skin may foe; exposed to one or more wavelengths of LED, laser or nonlaser light such as filtered filamentous sources or fluorescent sources or single or .multiple frequencies; of ultrasound.
  • A. variety - of parameters may be used (including pulse duration, energy, single or m ultiple pulses, the interval between pulses, t he total number of p ulses, etc) to deliver sufficient cumulative energy to interact with the agent or tissue complex. This results in the inhibition or desu-uction of the sebaceous oil gland or the supporting skin tissue through photomodulatory means, photothermal means, or combinations thereof, in an embodiment, these devices may be used by the patient for at-home treatment or as part of an ongoing skm-care system after receiving treatment by a physician.
  • the wavelength should roughly correlate with an absorption maxima fa the target cell or subcellular component or tissue, or exogenous chromophobe, ha some eases it may be desirable to target more than one maxima- either simultaneously or sequentially on the same or different treatment dates.
  • the presence of multiple maxima action spectra are common for a given cell or subcellular component or exogenous chromophore and different wavelength maxima irradiation may produce different results.
  • the lase diodes are also multicbroraatic with narrow wavelength bauds around a dominant band, i.e., they are nanovyhand multichromatic devices— devices which emit electromagnetic in a narrow band of radiation either symetrically or asymetrically around a dominant wavelength.
  • a ' narrowband ' mmiichromatic eieciiomagnetic radiation emitter emits eleciiomagneiic radiation in a bandwidth of +/- about : 1.00 nanometers around a dominant wavelength.
  • a narrowband mnltichromatic electromagnetic radiation emitter emits electromagnetic radiatio in a bandwidrb. of -* ⁇ / « aboiit. 20 nanometers around a dominant wavelength
  • a narrowband muHichromatic electromagnetic radiation emitter emits electromagnetic radiation In a bandwidt of ⁇ /- about 1.0 nanometers around, a dominant wavelength
  • a narrowband molticbromatic electromagnetic radiation emitter emits electromagnetic radiation in a bandwidth- of +/- about 6.5 nanometers around a dominant wavelength.
  • LEDS while not iaonochromatie, emit in such a narrow band as to be considered narrowband roultichroma ⁇ c emitters.
  • the narrow band allows photons of slightly different wavelengths to be emitted. This can potentially be beneficial for creating certain desirable rnulti photon interactions, in contrast, most
  • Tissue penetration depth may be di fferent than the tissue penetration depth for ulcerated or burned skin and. may also be. different for skin that has been : abraded, or enzymaticaily peeled or that has had at least a portion of the stratum, corneum. removed by any method. It is also important to penetrate any interfering chromophore that also absorbs at this same wavelength (e.g. dark ethnic skin, plastic Peine dishes for tissue or cell culture, etc.). It is important to penetrate any issties or organs in its pathway.
  • the selection, of th dominant wavelength of the radiation emitter i also dependent on the depth of treatment desired.
  • the selection of the proper wavelength is one of the significant parameters for effective use of the ' : present disclosure * bat others are important as well:
  • the energy density corresponds to the amount of energy delivered during irradiation and. is also referre to as energy intensity and light intensity. The optimal.
  • 'dose' is affected by pulse duration and wavelength thus, these are interrelated and pulse duration is very importan t— in general high energy produces inhibi tion and lower energy produces stimulation.
  • the exposure time for the irradiation is very critical and varies with the desired effect and the target ceil, subcellular eoraponerit, exogenous ehromophore tissue or organ (e.g. 0.5.microseconds to 10 rain may be effective for human fibroblasts, though greater or lesser may also be used successfully).
  • Suitable active agents for use in topical compositions applied to the skin by the applicator tip in accordance with the present disclosure include one or more of Vitamin C. Vitamin E, Vitamin D, Vitamin A. Vitamin K t Vitamin F. Retin A (Tretinoin), Adapaleue, Retinol, Hydroquinoiie, ojic acid, a growth factor, echinacea, an antibiotic, an antifungal, an • antiviral, a bleaching agent, an alpha hydroxy acid, a beta hydroxy acid, salicylic acid, antioxidant triad compound, .a seaweed deri ative, a salt water derivative, algae, m antioxidant, a phytoantlmeyanin, a hytonnirieat, plankton, a botanical product a- erbaceous product, a hormone, an nz me, a mineral, a genetically engineered substance, a cefaclor, a caiaiyst, an aniiaging substance, .
  • Vitamin C
  • a hair growth stimulating substance a hair growth inhibiting substance
  • a dye a natural or synthetic melanin, a metalloproteinase inhibitor, proline, ydroxyproline, an anesthetic substance, chlorophyll, bacteriochlorophyll, copper
  • chiorop!ryllin chloropiasts, qa oteno s, phyeobil n, rhodopsra, aiuhocyanm, and derivatives, subcomponents, immunological complexes and antibodies directed towards any component of the target skin structure or apparatus, and analogs of the above items both natural and synthetic, as well as combinations thereof.
  • topical compositions applied to the skin by the applicator tip include aiiti-wrinMe co.n pos.itioris (e.g., PRO-XYLANETM, and the like), anti- dark circle compositions (e.g., HALOXYLTM, and the like), or anti-poffiness compositions (e.g., FRI ALIFTTM, and the like).
  • aiiti-wrinMe co.n pos.itioris e.g., PRO-XYLANETM, and the like
  • anti- dark circle compositions e.g., HALOXYLTM, and the like
  • anti-poffiness compositions e.g., FRI ALIFTTM, and the like.
  • topical compositions applied to the skin by the applicator tip include xyloses, hydroxypropyl tetrahydropyrantrioi and the like.
  • active agents for use m topical compositions applied to the skin by the applicator tip include capryloyl salicylic acid, adenosine, 'adenosine triphosphate, retinol Imoleate, and the like.
  • an applicator assembly incl udes an applicator tip that is configured to apply a cyclical mechani cal force to a skin, surface area of a user and to deliver a skin formulation including one or more of Aoyktes GI 0-30 Alky Acrylate CrossPolymer, Adenosine, Alcohol, Argmine, B ' HT, B!S-PEG-1 S Methyl Ether Dimethyl Silane * Buiylene Glycol Caffeine, Capryioyi. Salicylic Acid ⁇ Caprylyl Glycol, Carbomer, centanrea cyaous flower water, ehlorhexidine digiucona e, chrysia. Citric Acid, Coco-Betadine,
  • a special 1 filter may also be added to reduce the IR component of the radiation that the target skin, or tissue is exposed to, as this is believed to unsymmeincally dampen the shape of the l ' 850 eurve. At 850-870 nm, there is believed to be a ' dose dependent' effect oil fibroblasts.
  • Fig. 7 sho s ⁇ a method of installing the lighting unit into the housing 12.
  • a slot or hole is created proximal to the applicator tip 20.
  • LED assembly ! 00 ' is inserted into the slot.
  • the wiring 104 for the LED assembly 1 Of is routed to a driver circuit and a power supply as will he explained below.
  • Fig. 8 shows a block diagram, of hardware components - used ' in:conjunclion. with, the LED assembly 1 0.
  • the LEDs in LED assembly are driven by an LED Driver Board 820, which in turn receives power from Power Supply 810.
  • Power Supply can be the same or di ferent from batteries 32 mentioned above.
  • LED Dri ver 820 can be included as part of microprocessor 34 mentioned above, or it can he an i ndependent component.
  • Fig, 8 also shows thai the LED Driver 820 can be connected to a light on/off control unit which.
  • the LED assembly includes an infrared- LEO unit 1 10 and a yellow LED unit 112, which each emit a cone-shaped beam of light
  • the LED units can be standard commercially available LEDs as known to a person of ordinary skill in the art.
  • the LEDs could be types LY G6SP-CADB ⁇ 36 ⁇ 1-2 (for providing the 55K ) .ftm wavelength) and VSMF4728- (for providing the 870 nm wavelength).
  • Fig. 9B shows that the LEDs 110 and ⁇ 1 are. spaced apart by : 4tnni. ⁇ and. the LEDs are spaced apart from the applicator tip by 1 ,2 mm.
  • the LEDS are. configured to emit light at an 80 degree cone angle, this produces, light intensity at 77 % with no tip occlusion from the applicator tip.
  • FIG. 10 shows an embodiment which further includes a hood 114 for explicitly defining or limiting the area of light emission on the skin.
  • F g- 1 shows that a lens 11 1 may be used in
  • the lens! 1 101 can- have positive or negati e focal length properties to achieve the desired emission of light, and can he made of any number of materials, such as, hut not limited to,, glass, plastic or resin.
  • the lens 1 101 may also diffuse o broaden the light exposure of a specific area.
  • an acrylic material placed external to the LED units may be used, to achieve such a diffusing lens.
  • a pulse scheme is used, for the light emissions on the skin surface.
  • a “code” refers to the poise scheme for various treatment regiment. This includes various factors such .as- ulse- length, i erpulse delay, and pulse repetition,
  • a treatment may comprise a pulse code of 250 msec "on” time, 100 msec “off time (or dark period), and 100 pulses.
  • This- roduces a total energy fluence, in J/cm 2 , of 25 seconds limes (lie power output level of the emitters. This permits a comparison of pulsed verses continuous wave treatment (die “code” for continuous wave treatment would be 1 pulse .
  • the present embodiment allows for use of a continuous light wave treatment that simulates a pulsed treatment This is accomplished by assuming, movement of the device over an isolated skm ' area as shown, in. Fig. 1.2. which is estimated, to produce a simulated 1 Hz "pulse" as viewed from a particular area on. the skin as shown, in Fig. 13. Therefore, the present embodiment provides the .advantage of simulating a pulsed treatment on the skin, area by using continuous wave treatment in combination with the natural .movement: of a user.
  • a plurality of LED assemblies 100 (which may include LED nite 1 10 and 112) are provided such that they surround the applicator tip 2.0, as shown in Figs, ⁇ 4 ⁇ and 14B.
  • the lens i 101 described above may optionally be provided with each LED assembly 100 to focus or diffuse the emitted light
  • the LED assembl 100 may be pro vided within the
  • Fig. 16 shows a method- -implemented by the applicator apparatus 10 described above.
  • the applicator tip assembly 20 performs a process of contacting and delivering a skin formulation to a skin surface ofa user according to the cyclic movement of the applicator tip described above.
  • the light -assembly 1 0 performs a process of emitting light continuously to the skin surface are. of the. user

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Electromagnetism (AREA)
  • Otolaryngology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Radiation-Therapy Devices (AREA)
  • Surgical Instruments (AREA)

Abstract

An apparatus and method is provided for skin treatment. The apparatus includes, an applicator assembly that includes an applicator tip which is configured to apply a normal cyclical mechanical force to. a skin surface, area of a user' and to deliver a skin formulation to a skin surface area, of a user. The apparatus further includes an electromagnetic energy assembly that includes at feast one electromagnetic energy source adjacent to of within the applicator assembly and configured to deliver a continuous electromagnetic energy : stimulus of a character and for a duration sufficient to penetrate one or more dermal layers within the skin surface area of a user.

Description

APPARATUS AND METHOD FOR SKIN TREATMENT USING CONTINUOUS LIGHT
BACKGROUND
Field
100011 The disclosure .herein generally relates to m apparatus ami method for skin treatm n which Incl udes applying skin formulations, typically to the skin area, which operate i the sonic frequency range, in. combination wi th electromagnetic radiation to the skin ares.
SUMMARY
P< >2J According io an embodiment, there is provided an apparatus including an applicator assembly thai includes an applicator tip which is configured to apply a cyclical mechanical force to a skin surface area of a user and to deliver a. skin formulation- to a skin surface area of a user. In an embodiment, the cyclical mechanical force includes a normal component. In an embodiment the cyclical mechanical force includes a shear component In an embodiment, the cyclical mechanical force includes and normal component and a shear component. In an e bo iment, the applicator tip is configured to apply a normal stress and a shear stress to a region of skin.
|OO03| The apparatus further includes an electromagnetic energy assembly that includes at least one -electromagnetic energ sourc adjacent to or within, the applicator assembly and configured to deliver a continuous electromagnetic energy stimulus of a character and for a dar tion sufficient to penetrate one or more dermal layers within, the skin surface area of a user. In an embodiment factors that affect penetration depth of electromagnetic energy in tissue include wavelength, frequency, intensity, duration, and the like.
JOOM] Noii limiting examples of electromagnetic energy sources i nclude electromagnetic energy emitters, fiber lasers, laser diodes, lasers, light-emitting diodes, mier cavity light- emitting diodes, organic Rght-em ng diodes, polymer ligto-etraitiag diodes, quaaiuffl dots, idtni-fest lasers, and the like.
|0005| According to an. embodiment, the at least one electromagnetic energy source is adjacent to an outer edge of the applicator assembly.
|Ο0Ο&] According to an. embodiment, the at leas one electromagnetic energy source comprises a plurality of light-enriiting diodes and is configured to concurrently or sequentially generate at least a first continuous electromagnetic energy stimulus having a peak emiss ive wavelength of abou t 5:90 nanometers and a second continu us electromaguetic exiergy stimulus having a peak emissive wavelength ranging from, about 850 nanometers to about 870 nanometers,
(8 071 According to an embodiment, the at feast one electromagnetic energy source is configured to produce a single dominant emissive wavelength via narrowband
rau khromatie radiation.
£0OO8| According to an embodiment, the single dominant emissive wavelength is about 590 ran.
{0009} According to an. embodiment, the at least on electromagnetic energy source includes at least one light emitting diode (LED),
00l Of Accordin to an embodiment, the at least one LED includes a first LED which emits tight at a dominant, emissive wavelength: -of about 590 am and a second LED which emits light at about 850-870 nm.
10011| According to an embodiment, the fi st LED emits visible yellow light and the second LED emits infrared light.
(00121 According to an embodiment* a ratio of power radiatio of th first LED to the second LED is 4: 1. |00J3| According to an embodiment, the first LED emits. Sight at about 4 milliwatts per square centimeter ( W/enr) and th second LED emits light a a out 1 mW cm2,
|0M4| Accordi ng to an embodiment, an energy uenee of the electromagnetic energy assembly received at the skin, surface area is less than about 4 J/cm2,
O01 S| According to an embodiment, the electromagnetic, energy assembly further
comprising a hood configured to limit an interrogation region on. the skin .
£991 &J According to an embodiment, the electromagnetic energy assembly further includes a lens configured to focus electromagnetic energy stimulus: emitted from the electromagnetic energy assembly to limit a» interrogation region oft the: skin.
|0017| According to an embodiment, the at least one electromagnetic energy source ncludes a plurality of electromagnetic energy sources which surround (he applicator assembly.
£0018} According to an embodiment, the electromagnetic energy assembly further
comprising a. diffusing lens configured to diffuse electromagnetic energy emitted Irons the electromagnetic energy assembly on the skin to spread an interrogation region on the skin, |901¾ According to an embodiment, the at feast one electromagnetic energy source is included within the applicator assembl .
|0O20| According to an etsibodiute.it, a method of skin treatment is provided, iffipiemented b a skin treatment apparatus, that includes applying a cyclical mechanical force to a skin surface area of a user of a character and for a dur tion sufficient to cause a compressive force on the skin surface area of a user and to affect the permeability of a skin formulation. The method further in cludes interrogating the skin, surface area of the user with, a con tinuous electromagnetic energy stimulus of a character and for duration sufficient to penetrate one or more dermal layers within the skin .surface area of a user.
£092-1! According to an embodiment, a method of skin treatment is provided, implemented by a skin treatment: apparatus, thai includes applying a cyclical mechanic l force to a skin surface area of a user of a character and for a dura ion sufficient to cause a compressi ve force and a shear force on the skin surface area, of a use and to affect the peraieahility of a skin formulation.
P&22J According to an embodmieni, the method includes applying the .cyclical, mechanical force to the skin surface area of a user of a character and for a duration sufficient to cause a compressive force on the skin surface area of a user -and to affect the permeability of a skin, formulation includes applying a substantially normal oscillating force to the skin surface area, f0023| According to an embodiment the method includes applying the cyclical mechanical force to the skin surface area of a use of a character and for a duration -sufficient to cause a compressive force on the skin surface are of a user and to affect the permeability of a skin formulation includes applying an normal mechanical force having an amplitude of .motion perpendicular to the surface of the skin ranging from about 0,01 inches to about 0.075 inches.
[09241 According to an embodiment, the method includes interrogating the skin surface area of the user with the continuous electromagnetic energy stimulus of a character and for a duratio sufficient to penetrate at least one or more dermal layers within the skin surface area of a user includes concurrently or sequentially emitting at least a first continuous
electromagnetic energy stimulus having a peak -emissive wavelength of about 590 nanometers and a second .'continuous electromagnetic energy stimulus having a peak emissive wavelength ranging from about 830 nanometers to about 870 nanometers,
[9925| According to an embodiment, the method includes interroga ing the skin surface area of the user with the continuous eleeiromsgnede energy stimulus of a character and for a duration sufficient to penetrate at least one or more dermal layers within the- skin surface area of a user includes concurrentl or sequentially emitting at least a first continuous
electromagnetic interrogation Stimulus having peak kradiance of about 4 milliwatts per square centimeter (mW/cm2) and emitting a second continuous electromagnetic ntterrogation stimulus having a peak, irradianee/at about 1 m /cruA
100261 According to an. embodiment, an electromagnetic energy assembly includes at least one electromagnetic energy source adjacent to or thiri the. applicator assembly and configured to deliver a continuous electromagnetic energy stimulus of a character and for a duration sufficient io penetrate one or more dermal, layers within the ski surface area of a user and to affect ^regulation of one or more epidermis-associated proteins,
dennoepiderniai^nnetioa-assoeiated proteins, or dermis-assoeiated proteins In the portion of skin.
|ββ27| According to an embodiment, an electromagnetic energy assembly includes at least one electromagnetic energy source adjacent to or within the applicator assembly and configured to deliver a continuous electromagnetic energy stimulus of a character and for a duration sufficient to penetrate one or more dermal layers within the skin surface are of a rjser and to affect tipregniation of one or more epidermal proteins selected from the group consisting of filagrin; transglutaminase 1 (TOO); glycoprotein (CD44); keratin 10 ( J9); keratin 1 ( 1.4); tenacin C; globular aciin '(ActinG); fibrillaractin (AeiinF) and syndecan 1. {00281 According to an entbodinteni, an electromagnetic energy assembly includes at least one- electromagnetic energy source adjacent to or within the applicator assembly and configured to deli ver a continuous 'electromagnetic energy stimulus of a character and for a duration sufficient to penetrate one or more dermal layers within the skin surface area of a user and to affect upregulaiio of one or more derenoepidermai. junction proteins selected from. the. group consisting of collagen 4 (Coil 4); collagen 7 (Coll. 7); lamiuin V; and perleeaa.
According to an embodiment, an electromagnetic energy assembly includes at least, one electromagnetic energy source adjacent to or within the applicator assembly and configured ίο deliver a continuous electromagnetic energy stimulus of a character and for a dardtion sufficient to penetrate one or .more dermal layers within, the skin surface area of a user and to affect ^regul ion of one or more dermal proteins selected from the group consisting of hyaluronati synthase 3 (HA$3); fibronectra; tropoeJastin; . procolli ; integrin; and decorift.
BRIEF DESCRIPTION OF THE DRAWINGS
00301 A more complete appreciation of the disclosure and many of the attendant advantages thereof will he readily obtained as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:
{00311 Fig. I illustrates an applicator apparatus according to an embodiment,
00321 Figs. 2A? 2B, 2C, and 2D illustrate a sequence of a desired motion of an applicator tip of the applicator apparatus.
190331 Fig. 5 is a cross-sectional diagram showing the overall operating parts contained within die applicato apparatus.
}0034{ Fig, 4 illustrates a first vie of the motor and its related components of the applicator apparatus.
190 51 Fig. 5 il l ustrates secon d vi ew of the motor and its related components of the applicator' pparatus.
{09 61 Fig. 6 'illustrates a third view of the motor and its related components of the applicator apparatus.
{99371 F s» 7A, 70, 7C, a».d 7D illustrate a .method of installing a lighting unit into a housing of the applicator apparatus. |0038J Fig. 8 shows a block diagram of hardware om one ts' used in conjunction with the LED assembly.
06391 Bgs. 9A and 9B illustrate details of the individual lighting- units contained in the LED assembly,
{00401 Fig. 1.0 illustrates an embodiment of the applicator apparatus which includes a hood. |§ I J Fig. 1 i illustrates an embodiment of the applicator apparatus which Mchides a lens. f0 421 Fig, 12 illustrates a particular method of using the applicator apparatus,
00431 Hg; 13 illustrates a pulsing of the rece ved light at the surface of the skin of a user hen the apparatus is used with movement.
|0i441 Figs, 14A and 14B illustrate an embodiment in which a plurality of light assemblies surround the applicator tip.
|0045| Figs. ISA and 15B illustrate an embodiment in which a light assembly is included within the applicator tip.
0046| Fig, 16 illustrates an embodiment of a process performed by the applicator apparatus, f60471 Like reference numerals designate identical or corresponding parts throughout the several views.
DETAILED DESCRIPTION
0 81 Power ap liances for applying skin fornruiatiorss, ty ically to t e-.skm area, which operate i the sonic frequency range, are effective for producing significant absorption of the skin rormulation to improve skin appearance, am are also comfortable' with respect to the physical contact between the applicator and the skin. Such an appliance, is described in U.S. Patent Nio. 8,469,909, which is owned. by the assignee of the present application, and the contents of which are incorporated by reference. |0049| Light therapy can be used for treatment o f ski n conditions usrag narrowband light Many such light therapy devices illuminate are very large and are used to illuminate the entire fac in a stationary manner,
OJ However, there is currently no device which, effectively combines the benefits of a sonic application of a skin f rmtdation with the benefits of light therapy into a single compact personal appliance that is convenient, inexpensive, and simple to use.
f 0051 J FIG. 1 shows an applicator appliance, is which one or more methodologies or technologies can be. implemented such as, for example, concurrently or sequentially
providing a normal cyclical mechanical .force and a plurality of electromagnetic stimuli to a fecial area of a u ser, in an embodiment, an applicator appliance includes a body portion 12, which is separate from a ca portion (not shown). Extending from the u er surface IS of bod portion 12 is an applicator tip 20 which contacts the skin of the user. In an
embodiment, the applicator ti 20 comprises one or more elastomeric materials. In an embodiment the applicator ti 2.0 comprises one or more polymeric materials. In an embodiment, the applicator tip 20 is formed from silicone. In an embodiment, the applicator tip 20 is formed- from super soft silicone having a shore 00-30 hardness. Further non-limiting examples of applicator tip materials include ethylene propylene dierte rubbers,
flourosilicones, chemical resistant materials, and the like.
in an embodiment, the applicator tip 20 comprises one or more waveguides operahiy coupled to at least one electromagnetic energy emitter. In an embodiment, the applicator ti 20 comprises on or more transparent, translucent, or ligh transmitting materials...
fe0S3i Among transparent, translucent, or light-transmitting materials, examples include those materials that offer a. low optical attenuation rate to the transmissio or propagation, of light waves, in an embodiment, the applicator tip 20 comprises one or more optically clear materials, semi-clear materials, plastics, thermo piastics, polymers, resins, thermal resins, and die like. I« an embodiment, the applicator tip 20 comprises one or more ofaceiaJ.
copolymers, acrylic, glass, Ag.Br, AgCt Α½0¾, GeAsSe glass, .BaF2i Gaf CdTe,: AsSeXe glass, Csi, -diamond, GaAs, Ge, ITRAN materials, Br, thallium bromide-Iodide, LiF, Mg.F; , NaO> polyethylene, Pyres., Si , Si(¾, ZnS, XnSe, thermoplastic polymers, thermoset
polymers, and the like,
|ii)54| Farther nan-.li«)iiihg. examples of op tically transparent, translucent, or iighi- transmitting materials include one or more of acrylonitrile butadaine slyrene polymers, celiulosic, epoxy; ethylene butyl aerylate, ethylene tetrafluoroethylene, ethylene vinyl
Figure imgf000010_0001
i«fluoromethoxy-l,3-diox le-co-ietrallttoroetliylen- e], pdly[2,2-bistriflttorQmethyl-4,5- difluo.ro- l,3-dioxole-eo-teirafl«oroeth- ykae], poly[2,3- <per8«orcalkenyl)perfl¾oi¾te rahydrofoi»n.' j, polyacry.lonitrile. butadiene styrene,
Figure imgf000010_0002
poiyeiliersitlforie, . polyethylene, oiyimide, qlymethyl methaerylaie, polynorboniene, polypertluoroalkoxyetbykhe,. polystyrene, poiysu!fone, po!yurethane, polyvinyl chloride, polyvinylideue fluoride, diaMyl phthalate, thermoplastic elastomer, transparent polymers, vinyl esters, and the like.
|0(*55f Irs an embodiment, the applicator tip 20 is configured to. deli ver continuous electromagnetic energy stimulus of a character and fo a duration sufficient to penetrate -one or more dermal layers within the skin sur&ee area of a user. For example, in an embodimen t, the applicator tip 20 comprises an optically transparent* translucent, or light-transmitting materials; is operably coupled to one or more electromagnetic energy emitters; and is configured to generate a continuous electromagnetic energy stimulu of a character and for a duration sufficient to penetrate one or more dermal layers within the skin surface area of a user, in an mibodinient, factors thai affect penetration depth of electromagnetic energy in tissue include wavelength, frequency, intensity, duration, and the like.
10056] In the embodiment shown, applicator tip 20 includes a concave portion 22 at a orward end thereof.. The concave portion will temporarily hold a selected, quantity of a skin limita ion which, is to be applied to the iter' facial, skin area daring operation of the appliance. Included, in the u er 'surface' 18 is a»..L.ED light assefnbly 100, the instaHatioft o which will be described in mo e detail later in this document. The appliance is controlled by an on/off switch (not shown).
}§§S7] For effective operation: of the appliance, specifically, operation which, produces effective absorption of the skin formulation, with a comfortable .contact 'between the
applicator tip and the user's skin, a complex motion of the applicator tip 20 has been found to be important A first component of the app licator tip motion is perpendicu l ar to the sur face of tire skin, a second componen of motion is parallel to the surface of the skin, and a third component is arcuate which results, in progressively increasing contact between the applicator tip and the skin.
199581 FIG. 2 shows a sequence of this desired motion. At time tO (FIG. 2 A), initial contact between applicator tip 20 and skin area 1 is shown. The inside edge 2 OA o f the applicator tip 20 comes first into contact with the surface of the skin 21. Force is beginning to be applied downwardly, perpendicular to the surface of the skin, producing an initial amoun of compressive force on the skin. Initial tensile stress is also produced on the skin 21. At time tl (PIG. .2B:)S applicator dp 20 is rotating clockwise as well as moving downwardly
perpendicular to and against the skin, continuing to compress the skin, as shown. In addition, the applicator tip moves to the left, parallel, to the surface of the skin .21. This parallel motion component produces a sufficient but relatively small tensile stress in the skin, which when combined with the compressive force lias been discovered to be important hi impro ving absorption of skm .formulations but withouf<l&TOaging the skin, or causing discomfort.
108591 The applicator tip motion changes at time 12 (FIG. 2C), and again at time B (FIG. 2 )S at whic point the contacting surface of the applicator tip is essentially parallel to the surface of the skin 21 with the contacting surface of the applicator tip in full contact with the skin, and wltk both the compressive force perpendicular to the ski and. th tensile stress parallel to the surface of the skin reaching a maximum value. The applicator tip produces a compressive force against the s kin along the entire contacting surface of the applicator tip, as shown in FIG. 2D, The motion -of the applicator ti then is reversed by motor action, with the applicator rip ending up at its initial position. The sequence 2A-2D is then repeated, at a selected frequency.
JOOSOf It has been discovered that the progressively increasing contact. between the surface of the skin due "to "the arcuate component of the applicator ti motion is important in
maintaining a comfortable contact, i.e. sensation, in the user. The above described motion, while complex, has the dual advantage of producing effective absorption, of the skin formulation as well as maintaining a satisfactory comfortable level of contact for the user,, such that the average user will continue to use the applicator. The complex motion, combined with the concave shape of the forward surface of the applicator tip, helps to keep the quantity o ski formulation present in me concave portion from being immediately displaced from th area of application on the user's skin.
i6t| FIG. 3 is a cross-sectional diagram showing the overall operating parts contained within the appliance body 12, The appliance body 12 includes a motor referred to generally at 30, which will he described in..more detail below, and a source of po wer, which in the embodiment shown are rechargeable batteries 32, but which could be other power sources as well, such as primary cells or an external power supply. The control, signal to th motor, as
I I well as other operational control functions, such as sensing the state of the on off switch -24, controlling tiie duration of a single applicatio use and monitoring battery charge state are provided by a microprocessor 34, Microprocessor 34 is conventional in structure and operation for such n a liance. All of the above parts are contained within housing portion
16 of body 12 of the appliance.
FIGS, 4-6 show the motor 30 for the appliance. in. more detail. The motor inclodes an anchor member 36 which is made from a stiff material: which, in the embodiment shown, is bard plastic. The anchor member i the embodiment shown, includes two slots 40 and 42' hich- are at right angles to each other, and which fit securely into corresponding rib elements 44 and 46 which are n of the boosing portion 1 (FIG. 3). The anchor member 36 is thus fixed in position in the housing and is not free to move during operation of the motor.
|0062| Motor 30 also includes an armature assembly 48 which includes two spaced permanent magnets 50 and 52 mounted, on a metal baekiron 51 (FIGS. 3, ). In the embodiment shown, the permanent magnets are spaced approximately 0.18 inches apart, but this can be varied. Further, the permanent magnets, in the embodiment shown, are 0.15 inches square by 0, 1 inches thick, 'although these dimensions can also vary.
{0063J A t one end 53 of the armature member 48 is a removable applicator tip assembly 56, at the forward end of which is positioned applicator ti .20. The applicator tip 20 is described in more detail in co-pending U.S, patent application Ser. No. 12/474,426, owned by th assignee of the present disclosure, the contents of which are hereby incorporated by reference. The applicator tip has a concave forward surface, to hold the skin formulation and is made from a very soft material, Shore scale OO Durometer 30. The flexibility of the material is similar to that of human skis and thus transmits motion and force efficiently. {00641 Positioned between anchor member 36 and armature. 8 is a electromagnetic stator assembly 60. The electromagnetic stator assembly 60 includes a conventional electromagnet 6.1 and an E-core laminated stack 62, the outer legs of which, m separated from the center leg 'by 0.257 inche and 0.267 inches,, respectively, in. th embodiment shown. The stator pole are the ends of th three legs. The siator assembly Is mou n ted to two opposing ribs 64 and 66 whi ch are also pari of hous i ng portion 16» Hence, in operation of the motor the stator assembly 60 also remains fixed irs position.
|0065J The motor further includes two l eaf springs 8' and 70 which extend between and connect anchor member 36 and opposing extending en portions 53 and 55 of 'armature 48. |0i66J The extending end portions of armature 48 are at right angles to each other. In the embodiment shown, the leaf springs are approximately 0.2 inches wide and.0,012 inches thick and are made of stainless steel The leaf springs 68 and 70 also extend approximately at .right angles to each other. Leaf springs 68 and 70. have different free lengths. The ratio of the free lengths of the leaf springs is important to achieve the desired rmtlii-component motion of the. applicator tip to produce effective and comfortable application of skin formulations. The rati of the length of. spring 70 to the length of spring 68 is within the range of 0.75: i to 0,95: 1 , In an embodiment, the tree length ratio is within the range of 0,79: 1 to 0.S3 : 1 , When the appliance is properly oriented relative t the skin, leaf spring 68 ill be approximately perpendicular to the skin, while leaf spring 70 will he approximately parallel wi th the skin . It is this arrangement of leaf springs, which produces the desired combination of effective absorption of skin formulation and com&rt to the user,
p0fr7| In operation, following actuation of the on/off switch 24, an alternating current electrical signal from microprocessor 34 is rovide to the electromagnetic stator assembly 60. During one ha lf cycle of the alternating current signal, the two outer poles of the electromagnet will attract one of the permanent magnets and repel the other permanent magnet The center pole will also repel one permanent, magnet while attracting the other. The resulting force moves -armature 48:, including the applicator tip, in a complex slightly arcuate motion counterclockwise (as viewed in FIG. 5) relative to the stator assembly 60 and toward the skin. This motion, as indicated above, a d. as shown, in FIG . 2A-2D, includes a
component of perpendicular motion, a component of parallel motion and a small component of arcuate motion. On the o ther half cycle, the direc tion of 'the- current i s reversed, and the armature responds by moving the tip applicator away from the skin in a clockwise direction relative to the stator.
|®96S| The frequency of the action is typically within a range of 50-200 Hz. In an embodiment, the .frequency of the action ranges from, about of 110 Hz "to about 135 Ηζ·. The range of amplitude 'of the motion, perpendicular to the surface of the skin j$ within the range of 0.01 inches to 0.075 inches, in an embodiment., the range ofamplita.de of the motion perpendicular to the surface of the skin ranges if a m about 0.02 inches to about 0.035 inches. The range of motio parallel, to the surface of the skin is within the range of 0.005 inches to 0.07 inches. In an embodimeni, the range of motion parallel to the surface of ihe skin ranges from about 0,013 inches to about 0.032 inches. The arcuate- motion that results from these dimensions is relatively small, following a» arc in the range of 0.5°-3°. in an embodiment, the arcuate motion thai results from these dimensions is about 2 although this value will vary with the actual dimensions used.
I operation, leaf springs 68 and 70 act to both center fee armature when i t is at rest and to produce a mechanicall resonant system when combined with the mass of the moving armature and the applicator tip assembly. When the electrical current alternates direction at a frequency - roughly equal to the mechanical resonance of the overall system, the amplitude of motion of the armature structure increases significantly, thus producing the required motion for effective action with the desired high efficiency relative to the electrical power input. Hence, the appliance is both effective in producin rapid and effective absorpiioa of the skin formulation, but also is a practical appliance to operate. |O070j In one embodiment, the above-described structure further includes single -or multiple light sources, to produce either a single dominant-emissive wavelength, i.e., la 'narrowband maUichromatie radiation, or multiple wavelengths (either monochromatic, narrowband midilehroma ic, wideband muitichromatie, or combinations -thereof). The single or multiple combinations m be applied either simultaneously or sequentially,
(0071 J Al hou h preferred, embodiment of the present disclosure may use LEDs, ultrasound and/or laser or light energy, the present disclosure is not limited to the use of these energy sources. Other sources of energy, including (without limitation) microwave energy and radio frequency energy may also he used. Exemplary of -known light so rces are uoreseent lights, fiash!anips, filamentous lights, etc. One skilled in the art will recognize that any light source capable of emitting electromagnetic radiation at a medically useful wa velength, as described herein, directly, or by means of optical filtration, is within the scope of suitable light sources according to the present disclosure. For purposes of the photomodulatory and phoiotherraal treatment methods described, any source capable of emitting light havin a wavelength from about 300 »m to about 1 00 am, or producing electromagnetic radiation which is filtered or otherwise altered to exposure the skin, a topical composition, or -other component of the present treatmen t regime to a wavelength of light in the aforementioned range is medically useful.
|9Θ72| The targeted skin may foe; exposed to one or more wavelengths of LED, laser or nonlaser light such as filtered filamentous sources or fluorescent sources or single or .multiple frequencies; of ultrasound. A. variety - of parameters may be used (including pulse duration, energy, single or m ultiple pulses, the interval between pulses, t he total number of p ulses, etc) to deliver sufficient cumulative energy to interact with the agent or tissue complex. This results in the inhibition or desu-uction of the sebaceous oil gland or the supporting skin tissue through photomodulatory means, photothermal means, or combinations thereof, in an embodiment, these devices may be used by the patient for at-home treatment or as part of an ongoing skm-care system after receiving treatment by a physician.
|0673| Wavelength— Each target ceil or subcellular component or molecular bond therein, tends to .have at least one nique and .characteristic "action spectrum" at which t exhibits certain electromagnetic or light absorption peaks or maxima. Different cell tines fo.ft.be same cell— for example fibroblasts from.3 differen patients) exhibit same differences in. their absorption spectra and thus using narrow band, multicliromatic light (rather than
monochromatic light) is also useful in producing the optimal ciinicai effect. When these cells or subcellular components are irradiated with wavelengths corresponding to the absorptioi'!. peaks or maxima, energy is -transferred f om the light photon and absorbed by the target The particular features of the delivered energy determine the cellular effects. The complexity of these combinations of parameters has produced muc confusion in the prior art. Basically, the wavelength should roughly correlate with an absorption maxima fa the target cell or subcellular component or tissue, or exogenous chromophobe, ha some eases it may be desirable to target more than one maxima- either simultaneously or sequentially on the same or different treatment dates. The presence of multiple maxima action spectra are common for a given cell or subcellular component or exogenous chromophore and different wavelength maxima irradiation may produce different results.
1087 1 if the wavelength hand is overly broad, then the desired photomodulatiori effects may be altered .from those intended. Consequently, use of broad band noncoherent intense tight sources may be less- desirable than those specified for use with the present disclosure, in contrast to the use of multiple narrowband emitters. The lase diodes are also multicbroraatic with narrow wavelength bauds around a dominant band, i.e., they are nanovyhand multichromatic devices— devices which emit electromagnetic in a narrow band of radiation either symetrically or asymetrically around a dominant wavelength. In an embodiment, a 'narrowband 'mmiichromatic eieciiomagnetic radiation emitter emits eleciiomagneiic radiation in a bandwidth of +/- about : 1.00 nanometers around a dominant wavelength. In an embodiment, a -narrowband maUichramatie electromagnetic radiation emitter em ts
electromagnetic radiation, in. a bandwidth of +/- about 50 nanometers around a dominant wavelength. In .an. embodiment, a narrowband mnltichromatic electromagnetic radiation emitter emits electromagnetic radiatio in a bandwidrb. of -*·/« aboiit. 20 nanometers around a dominant wavelength, in an embodiment, a narrowband muHichromatic electromagnetic radiation emitter emits electromagnetic radiation In a bandwidt of ÷/- about 1.0 nanometers around, a dominant wavelength, in an. embodiment, a narrowband molticbromatic electromagnetic radiation emitter emits electromagnetic radiation in a bandwidth- of +/- about 6.5 nanometers around a dominant wavelength. LEDS, while not iaonochromatie, emit in such a narrow band as to be considered narrowband roultichroma^c emitters. The narrow band allows photons of slightly different wavelengths to be emitted. This can potentially be beneficial for creating certain desirable rnulti photon interactions, in contrast, most
commercial lasers emit light at a single wavelength of light and are considered
monochromatic. The use of lasers, according to the prior art, has relied npon the coherent, i.e., monochromatic, nature of their electromagnetic emissions.
|007S| Wavelength' may also determine tissue penetration depth. It is important for the desired wavelength to reach the 'target cell tissue or organ. Tissue penetration depth for intact skin may be di fferent than the tissue penetration depth for ulcerated or burned skin and. may also be. different for skin that has been: abraded, or enzymaticaily peeled or that has had at least a portion of the stratum, corneum. removed by any method. It is also important to penetrate any interfering chromophore that also absorbs at this same wavelength (e.g. dark ethnic skin, plastic Peine dishes for tissue or cell culture, etc.). It is important to penetrate any issties or organs in its pathway. |0076| For example,, light having a dominant wavelength emission in the range of about 400 ran to about 420 um has -such, a short wavelength that iot all sebaceous glands or acne cysts can be effectively treated due to the li mited depth of penetration of the radiation, whereas light having a wavelength of about 600 ran to about 660 ran can more easily penetrate to a .greater depth, if treatment of the lower dermal layers or even deeper is desirable.
Accordingly, the selection, of th dominant wavelength of the radiation emitter i also dependent on the depth of treatment desired. The selection of the proper wavelength is one of the significant parameters for effective use of the': present disclosure* bat others are important as well:
|0077| Energy Densit— The energy density corresponds to the amount of energy delivered during irradiation and. is also referre to as energy intensity and light intensity. The optimal.
'dose' is affected by pulse duration and wavelength thus, these are interrelated and pulse duration is very importan t— in general high energy produces inhibi tion and lower energy produces stimulation.
&781 Pulse duration The exposure time for the irradiation is very critical and varies with the desired effect and the target ceil, subcellular eoraponerit, exogenous ehromophore tissue or organ (e.g. 0.5.microseconds to 10 rain may be effective for human fibroblasts, though greater or lesser may also be used successfully).
10 91 Continuous Wave (CW) vs.. ulsed1— e..g. the optimal pulse duration is affected by these parameters. In general, the energy requirements are different if pulsed mode is used compared to continuous (CW) modes. Generally, the poised mode is preferred for certain, treatment regimen and the CW mode for others.
{66861 Frequency (if pulsed)— -e.g. higher frequency tends to be inhibitory while lower frequency tends to be stimulatory, but exceptions may occur. |ββ8Ι I .Duty cycle— his is the device Light output repetition cycle whereby the irradiation is repeated, at periodic intervals, also referred to herein as the i erpulse delay (time between pulses when the treatment session, comprises a series of pulses).
i82 Suitable active agents for use in topical compositions applied to the skin by the applicator tip in accordance with the present disclosure include one or more of Vitamin C. Vitamin E, Vitamin D, Vitamin A. Vitamin Kt Vitamin F. Retin A (Tretinoin), Adapaleue, Retinol, Hydroquinoiie, ojic acid, a growth factor, echinacea, an antibiotic, an antifungal, an antiviral, a bleaching agent, an alpha hydroxy acid, a beta hydroxy acid, salicylic acid, antioxidant triad compound, .a seaweed deri ative, a salt water derivative, algae, m antioxidant, a phytoantlmeyanin, a hytonnirieat, plankton, a botanical product a- erbaceous product, a hormone, an nz me, a mineral, a genetically engineered substance, a cefaclor, a caiaiyst, an aniiaging substance, . insulin, trace elements {including ioni calcium, magnesium, etc), minerals, Rogaine, a hair growth stimulating substance, a hair growth inhibiting substance, a dye, a natural or synthetic melanin, a metalloproteinase inhibitor, proline, ydroxyproline, an anesthetic substance, chlorophyll, bacteriochlorophyll, copper
chiorop!ryllin, chloropiasts, qa oteno s, phyeobil n, rhodopsra, aiuhocyanm, and derivatives, subcomponents, immunological complexes and antibodies directed towards any component of the target skin structure or apparatus, and analogs of the above items both natural and synthetic, as well as combinations thereof.
p0831 Further non-limiting examples of topical compositions applied to the skin by the applicator tip include aiiti-wrinMe co.n pos.itioris (e.g., PRO-XYLANE™, and the like), anti- dark circle compositions (e.g., HALOXYL™, and the like), or anti-poffiness compositions (e.g., FRI ALIFT™, and the like).
39 |0984| Further iioa-Hmitin examples of active agents for use to. topical compositions applied to the skin by the applicator tip include xyloses, hydroxypropyl tetrahydropyrantrioi and the like.
f0085J Further non-limiting examples of active agents for use m topical compositions applied to the skin by the applicator tip include capryloyl salicylic acid, adenosine, 'adenosine triphosphate, retinol Imoleate, and the like.
fiMIS&! In an embodiment an applicator assembly incl udes an applicator tip that is configured to apply a cyclical mechani cal force to a skin, surface area of a user and to deliver a skin formulation including one or more of Aoyktes GI 0-30 Alky Acrylate CrossPolymer, Adenosine, Alcohol, Argmine, B'HT, B!S-PEG-1 S Methyl Ether Dimethyl Silane* Buiylene Glycol Caffeine, Capryioyi. Salicylic Acid^ Caprylyl Glycol, Carbomer, centanrea cyaous flower water, ehlorhexidine digiucona e, chrysia. Citric Acid, Coco-Betadine,
Cyclohexasiloxane, dimeihieone, Disodium Ethylenediannneteimcetic acid (EDTA), Glycerin, Hydregenated Lecithin, Hydroxypropyl Tetrahydrppyrantripl, Laitrayl Lysine, Methyl Gliteeih-20, N-Hy-droxysuccmimide, Octyldodecanol,. Pahnitoyl Oligopeptide, Pahmtoyl Tetrapepiide-7, Polyethylene Glycol (PEG)-20:, Penty len Glycol, Phenoxy thaaoi, Polysilieone-l l., Potassium. Sorbate, Propanediol, Propylene Glycol, Sodium Hydroxide, Squalane, Steareih-20, Toeopheryl acetate, Water, Xanthan Gum, Yeast- E tracts and the like. &87J in an example a device emits narrowband, mu!tichromaiic electromagnetic radiation with a dominant emissive wavelength of about 590 nra ( · - about 10 nm) and also some light in the 830-870 ran range and, optionally, a small amount In the 1.060 nm range, it has been discovered that the combination of the visible 590 and the infrared 850-8.70 am is htoaciive. A special 1 filter may also be added to reduce the IR component of the radiation that the target skin, or tissue is exposed to, as this is believed to unsymmeincally dampen the shape of the l' 850 eurve. At 850-870 nm, there is believed to be a 'dose dependent' effect oil fibroblasts. Further, at a power lev el of about I mW/cm2, pliotomodulaiion occurs for anii aging phenotype effec (those skilled in the art will recognize thai power meters cannot measure this precisely, so there may be some variation error in meter methods); Generally, where a treatment tha does not cause thermal injury is desired, an energy Ouenee of less than about 4 J cor (-h/~ o.S J cm?) is preferable.
|008$] The ratio of yellow light to IR radiation in the radiation used for treatment has been found to have an. effect on the overall performance of the present system. Specifically, through testing with nioPoehro eter and single wavefettgih LBDs, and later using ratio. ONA mJeroarrays studies it was determined that one specific combination ratio of yellow and IR was very effective for wrinkles. Relative amounts of each type of radiation are believed to be important-more' s than the actual radiation level (provided that ablation does not occur). At about 4 mW/cna3 (+/- about 0.-5 mW c:ro2) for 590 am and about 1 mW/era2 (+ - about 0.5 mW/cm2) for the 850-870 am (i.e., a 4; 1 ratio of yellow to IR) has been foun to produce good results. Another factor to consider is the shape of the amplitude vs. wavelength curve fo the IR component of the system.
00891 Fig. 7 sho s^ a method of installing the lighting unit into the housing 12. As shown in Fig, 7A, a slot or hole is created proximal to the applicator tip 20.- As shown in Fig, 7B and 7C, LED assembly ! 00 'is inserted into the slot. As shown in Fig. ?D; the wiring 104 for the LED assembly 1 Of) is routed to a driver circuit and a power supply as will he explained below.
i98| Fig. 8 shows a block diagram, of hardware components - used' in:conjunclion. with, the LED assembly 1 0. The LEDs in LED assembly are driven by an LED Driver Board 820, which in turn receives power from Power Supply 810. Power Supply can be the same or di ferent from batteries 32 mentioned above. Additionally, LED Dri ver 820 can be included as part of microprocessor 34 mentioned above, or it can he an i ndependent component. Fig, 8 also shows thai the LED Driver 820 can be connected to a light on/off control unit which.
■receives- an input from the user -to toggle on/off the LE -units.
|009J| Fig. shows thai the LED assembly includes an infrared- LEO unit 1 10 and a yellow LED unit 112, which each emit a cone-shaped beam of light The LED units can be standard commercially available LEDs as known to a person of ordinary skill in the art. For instance, the LEDs could be types LY G6SP-CADB~36~1-2 (for providing the 55K).ftm wavelength) and VSMF4728- (for providing the 870 nm wavelength).
|0i.92| Fig. 9B shows that the LEDs 110 and ί 1 are. spaced apart by:4tnni.} and. the LEDs are spaced apart from the applicator tip by 1 ,2 mm. When the LEDS are. configured to emit light at an 80 degree cone angle, this produces, light intensity at 77 % with no tip occlusion from the applicator tip.
|0093| Fig. 10 shows an embodiment which further includes a hood 114 for explicitly defining or limiting the area of light emission on the skin.
(i094| In an alternative embodiment F g- 1 shows that a lens 11 1 may be used in
conjunction with each LED unit 100 to limit the light to a specific area so that the hood shown in Fig, 1 will be unnecessary. The lens! 1 101 can- have positive or negati e focal length properties to achieve the desired emission of light, and can he made of any number of materials, such as, hut not limited to,, glass, plastic or resin. The lens 1 101 may also diffuse o broaden the light exposure of a specific area. In one example, an acrylic material placed external to the LED units may be used, to achieve such a diffusing lens.
P«95J In conventional light therapy systems, a pulse scheme is used, for the light emissions on the skin surface. A "code" refers to the poise scheme for various treatment regiment. This includes various factors such .as- ulse- length, i erpulse delay, and pulse repetition, For example a treatment may comprise a pulse code of 250 msec "on" time, 100 msec "off time (or dark period), and 100 pulses. This- roduces a total energy fluence, in J/cm2, of 25 seconds limes (lie power output level of the emitters. This permits a comparison of pulsed verses continuous wave treatment (die "code" for continuous wave treatment would be 1 pulse., an "on" lime of whatever fee treatment length, is ehosen to bey and ¾« "off time of 0 sec.) ft>i96 The present embodiment, allows for use of a continuous light wave treatment that simulates a pulsed treatment This is accomplished by assuming, movement of the device over an isolated skm' area as shown, in. Fig. 1.2. which is estimated, to produce a simulated 1 Hz "pulse" as viewed from a particular area on. the skin as shown, in Fig. 13. Therefore, the present embodiment provides the .advantage of simulating a pulsed treatment on the skin, area by using continuous wave treatment in combination with the natural .movement: of a user. p§97| in a modification to the embodiment described above, one. r a plurality of LED assemblies 100 (which may include LED nite 1 10 and 112) are provided such that they surround the applicator tip 2.0, as shown in Figs, Ι4Λ and 14B. The lens i 101 described above may optionally be provided with each LED assembly 100 to focus or diffuse the emitted light
190981 In another modification, the LED assembl 100 may be pro vided within the
applicator tip itself as shown in Figs. I SA and 15B. The lens Π0Ί described above may optionally be provided with the LED assembly 100 to focus or diffuse the emitted light, 99991 Fig. 16 shows a method- -implemented by the applicator apparatus 10 described above. In: step .1610, the applicator tip assembly 20 performs a process of contacting and delivering a skin formulation to a skin surface ofa user according to the cyclic movement of the applicator tip described above. Simultaneously., in ste .1.620, the light -assembly 1 0 performs a process of emitting light continuously to the skin surface are. of the. user
'according to the light emission of the speci fic light described above. These two processes can be started and ended at separate times according to separate on/off switches, or they can be started and eiided simultaneously 'according to the same on/off switch (such as the on/off switch shown, in Fig. 8).
|88J 001 Numerous mod fications and variations of the present disclosure are possible in light of he bove teachings, It is therefore to be. understood t hat within the scope of the appended claims, the claimed invention may be practiced otherwise than as specifically described herein.

Claims

WHAT IS CLAIMED IS:
] ... An apparatus comprising".
an applicator assembly thai includes an applicator tip which is configured to apply a normal 'cyclical mechanical force to a skin surface area of a user and to delive a skin formulation to a skin surface area of a user; and
an electromagnetic energy assembly that includes at least one electromagnetic energy source adjacent to or within the applicator assembly and configured to deliver a continuous electromagnetic energy stimulus- of a character and for a duration su fficient to penetrate one -Or -more dermal layers within the skin surface area of a user.
2. The apparatus according t ela-im L wherein the at least one electromagnetic, energ sourc is adjacent to an outer edge of the applicator assembly.
3. The apparatus according to claim 1 s wherein the at least one "electromagnetic energ source comprises a plurality of Jight-emitttug. diodes and is configured to concurrently or sequentially generate at least a first continuous, electromagnetic' energ stimulus having a peak emissi ve wavelengt of about 590 nanometers and a second continuous electromagnetic energy stimulus having a peak emissive wavelength ranging, from about 850 nanometers, to. about 870 nanometers.
4. The apparatu according to claim 1, wherein the at least one electromagnetic energ source is configured to produce a single dominant emissive wavelength via
narrowband multichromatic radiation.
5. The apparatus according to claim 4, wherein the single dominant emissive wavelength is about 590 nm.
6. The apparatus according- to claim 1, wherein the at least one electromagnetic e ergy source includes at least one light emitting diode (LED),
7. Th apparatus according to claim 6, wherein the at least one light, emitting. diode
(LED) includes a first light emitting diode (LED)which emits light al a dominant emissive wavelength of about 590 nanometers and a second light emitting diode (LED) which emits light at about 850-870 nanometers,
8. The apparatus according to claim 7, wherein the first light emitting diode (LED) emits visible yellow light and the second light emitting diode (LED) emits infrared light.
9. The apparatus according to claim 8, wherein ratio of power radiation of the first li ht emitting diode (LED) to the second light .emitting diode (LED) is 4:1.
.
10. The apparatus according to -claim ·9„ wherein the first light emittin diode (LED) emits Sight at about 4 milliwatts per square eenthneter (mW/cm2) and the second ligh emitting diode (LED) emits light at about 1 m W em2.
1 1. The apparatus according to claim L wherein an energy fluence of the electromagnetic energy assembiv received at the skin surface area is less than about 4 J em2.
12. The apparatus according to claim 1, the electromagnetic energy assembly further comprising a hood configured to limit an interrogation region on the skin.
13. The apparatus according to claim ]., the electromagnetic energy assembly further comprising a lens configured t focus -electromagnetic .energy stimulus emitted from the eieetromagiietie energy assembly to liraijr. an interrogation region on the skin.
1 . The apparatus according to claim ls wherein the at least one electromagnetic energy source includes a plurality of electromagnetic energy sources which, surround the applicator assembly,
15. The apparatus according to claim 14, the electromagnetic energy assembly further comprising a. dilTusing lens configured to diffuse electromagnetic energy emitted from the electromagnetic energy assembly on the skin to spread an interrogation region on the skin.
1 . The 'apparatus' according to claim 1, wherein the at: least one electromagnetic energy source is included within the applicator assembly.
17. A rnethod of skin treatment, impleme ted by a skin treatment apparatus, comprising:
applying a cyclical mechanical force to a skin surface area of a user of a character and for a duration sufficient to cause a compressive force on a region of skin of a user and to 'affect the permeability of a skin, formufotion; and interrogating the region of skin of the user with a continuous electromagnetic energ stimulus of a character arid for a duration, sufficient to penetrate one or more dermal layers within the skm region of a user.
18, The method of skin treatment of claim Π, wherein applying the cyclical mechanical force to the skin region of a user of a character and for a duration sufficient to cause a compressive force on the skin region of a user and to affect the permeability of a skin .formulation inelodes applying, a substantially normal oscillating force to the skin region.
19, The method of skin treatment of claim 175 wherein applying the cyclical mechanical force to the skin region of a user of a character and for a duration sufficient io cause a compressive force on the skin region of a user and. to affect the permeability of a skin formulation includes applying an normal mechanical force having an amplitude of motion substantially perpendicular to the surface of the skin region ranging from about 0.01 inches to about 0,075 inches.
20, The method of skin trea&nent of claim 17,, wherein interrogating the skin region of the user: with the continuous electromagnetic energy stimulus of a character and for a duration sufficient to -penetrate at least one or more derma! layers within, the skin region of a user includes concurrently or sequentially emitting at least a first continuous electromagnetic energy stimulus having peak emissi ve wavelength of about 590 nanometers and a second continuous electromagnetic energy stimulus having a peak emissive wavelength ranging from about 850 nanometers to about 870 nanometers.
21. The method of skin treatment of claim Ϊ 7, wherein interrogating the skin, region of the user with the continuous electt x>.magneri c energy stimulus of a character and for a duration sufficient to penetrate at least one or more dermal layers within the skin region of a user includes delivering a continuous electromagnetic energy stimulus- of a character and for a dura tion suffi cient to penetrate one or more dermal lay ers within the .skin region and to affect upregnlation of one or more epidermis-associated proteins, ermoepidermai~junction~ associated proteins, or dermis-associated proteins within the skin region,
22. The method of skin treatment of data* 17, wherein interrogating the skin region of the «ser with the continuous electromagnetic energy stimulus of a character and for a duration sufficien t to penetrate- at least one or more dermal layers within the skin region of a user includes delivering a continuous electromagnetic energy stimulus of a character and for a duration sufficient to penetrate one or more dermal layers and to activate one or more active agents within the one or more dermal layers.
23. The method of -skin treatment of claim 17, wherein interrogating the skin, region of the user with the continuous electromagnetic energy stimulus of a character and for a duration sufficient to penetrate at least one or more dermal layers within the skin region of a user includes concurrently or sequentiall emitting: at least a first continuous electromagnetic interrogation stimulus having a peak irradiance of about 4.milliwatts per square centimeter (mW/ero2) and emi ttin a second con tin uous electromagnetic interrogation -stimulus having a peak irradiance at about 1 raW/cra2.
PCT/US2016/016329 2015-02-03 2016-02-03 Apparatus and method for skin treatment using continuous light WO2016126793A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1020177021793A KR102132417B1 (en) 2015-02-03 2016-02-03 Skin treatment device using continuous light
EP16747171.3A EP3240609B1 (en) 2015-02-03 2016-02-03 Apparatus for skin treatment using continuous light
CN201680008650.8A CN107206250B (en) 2015-02-03 2016-02-03 The device and method of skin treatment are carried out using continuous light
JP2017540701A JP7040942B2 (en) 2015-02-03 2016-02-03 Equipment and methods for skin care using continuous light
BR112017014275A BR112017014275A2 (en) 2015-02-03 2016-02-03 ? apparatus and method of skin treatment?

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/613,125 US9687643B2 (en) 2015-02-03 2015-02-03 Apparatus and method for skin treatment using continuous light
US14/613,125 2015-02-03

Publications (1)

Publication Number Publication Date
WO2016126793A1 true WO2016126793A1 (en) 2016-08-11

Family

ID=56553692

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/016329 WO2016126793A1 (en) 2015-02-03 2016-02-03 Apparatus and method for skin treatment using continuous light

Country Status (7)

Country Link
US (1) US9687643B2 (en)
EP (1) EP3240609B1 (en)
JP (1) JP7040942B2 (en)
KR (1) KR102132417B1 (en)
CN (1) CN107206250B (en)
BR (1) BR112017014275A2 (en)
WO (1) WO2016126793A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114397392A (en) * 2022-01-18 2022-04-26 宁波中盛产品检测有限公司 Ion chromatographic analysis method for vitronectin effective substances in cosmetics
US11523878B2 (en) 2017-11-14 2022-12-13 Micron Machinery Co., Ltd. Handpiece-type high-frequency vibration cutting device

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD752237S1 (en) 2015-03-03 2016-03-22 Carol Cole Company Skin toning device
EP3281598A1 (en) * 2016-08-09 2018-02-14 Koninklijke Philips N.V. Light based skin treatment device and method
USD854699S1 (en) 2018-05-15 2019-07-23 Carol Cole Company Elongated skin toning device
WO2020010391A1 (en) * 2018-07-13 2020-01-16 International Scientific Pty Ltd A method and apparatus for enhanced transdermal, intradermal or transappendageal delivery of retinoids
WO2020010388A1 (en) * 2018-07-13 2020-01-16 International Scientific Pty Ltd A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients
WO2020010389A1 (en) * 2018-07-13 2020-01-16 International Scientific Pty Ltd A method and apparatus for enhanced transdermal, intradermal or transappendageal delivery of titanium dioxide
WO2020010390A1 (en) * 2018-07-13 2020-01-16 International Scientific Pty Ltd A method and apparatus for enhanced transdermal, intradermal or transappendageal delivery of hyaluronic acids
US10881882B1 (en) * 2018-12-21 2021-01-05 Btl Medical Technologies S.R.O. Methods and devices for tissue treatment
USD953553S1 (en) 2020-02-19 2022-05-31 Carol Cole Company Skin toning device
USD957664S1 (en) 2020-07-29 2022-07-12 Carol Cole Company Skin toning device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100121254A1 (en) * 1998-11-30 2010-05-13 Mcdaniel David H Method and apparatus for skin treatment
WO2011051941A1 (en) * 2009-10-29 2011-05-05 Synoia Technologies Ltd Multi-application skin care system
WO2012131672A2 (en) * 2011-04-01 2012-10-04 Syneron Beauty Ltd A treatment device
US8469909B2 (en) * 2009-05-29 2013-06-25 L'oreal, Sa Motor for a personal skin care appliance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7931028B2 (en) * 2003-08-26 2011-04-26 Jay Harvey H Skin injury or damage prevention method using optical radiation
JP4398813B2 (en) * 2003-07-18 2010-01-13 ヤーマン株式会社 Skin care equipment
ES2572976T3 (en) * 2003-07-31 2016-06-03 Gentlewaves Llc System and method for photodynamic skin treatment
KR200335313Y1 (en) * 2003-08-13 2003-12-06 주식회사 프로스인터네셔날 Alopecia-healing comb using LASER and LED
JP2006192073A (en) * 2005-01-13 2006-07-27 Matsushita Electric Ind Co Ltd Phototherapy apparatus
US20090254155A1 (en) * 2008-04-04 2009-10-08 Medical Quant Usa, Inc. Dba Multi Radiance Medical Therapeutic emitter retaining device
US8523791B2 (en) * 2009-08-11 2013-09-03 Laboratoire Naturel Paris, Llc Multi-modal drug delivery system
US10252051B2 (en) * 2010-07-01 2019-04-09 Thomas Nichols Handheld facial massage and light therapy device
US20130190845A1 (en) 2012-01-25 2013-07-25 Tria Beauty, Inc. Edge-Lit Apparatus and Methods for Providing Light-Based Therapy

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100121254A1 (en) * 1998-11-30 2010-05-13 Mcdaniel David H Method and apparatus for skin treatment
US8469909B2 (en) * 2009-05-29 2013-06-25 L'oreal, Sa Motor for a personal skin care appliance
WO2011051941A1 (en) * 2009-10-29 2011-05-05 Synoia Technologies Ltd Multi-application skin care system
WO2012131672A2 (en) * 2011-04-01 2012-10-04 Syneron Beauty Ltd A treatment device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP3240609A4 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11523878B2 (en) 2017-11-14 2022-12-13 Micron Machinery Co., Ltd. Handpiece-type high-frequency vibration cutting device
CN114397392A (en) * 2022-01-18 2022-04-26 宁波中盛产品检测有限公司 Ion chromatographic analysis method for vitronectin effective substances in cosmetics
CN114397392B (en) * 2022-01-18 2023-08-11 宁波中盛产品检测有限公司 Ion chromatography analysis method for vitronectin effective matters in cosmetics

Also Published As

Publication number Publication date
JP2018503476A (en) 2018-02-08
CN107206250A (en) 2017-09-26
US9687643B2 (en) 2017-06-27
JP7040942B2 (en) 2022-03-23
CN107206250B (en) 2019-07-02
EP3240609B1 (en) 2020-06-17
EP3240609A4 (en) 2018-10-17
US20160220804A1 (en) 2016-08-04
EP3240609A1 (en) 2017-11-08
KR102132417B1 (en) 2020-07-09
KR20170125325A (en) 2017-11-14
BR112017014275A2 (en) 2018-03-27

Similar Documents

Publication Publication Date Title
WO2016126793A1 (en) Apparatus and method for skin treatment using continuous light
EP3253452B1 (en) Apparatus for skin treatment using pulsed light
US10624700B2 (en) Acccessory for electromagnetic handpiece
CA2452408C (en) Method and apparatus for the photomodulation of living cells
US8568463B2 (en) Hair growth modulating method and modulation device thereof
NO20033237L (en) Photodynamic simulation device and method
EP3104926A1 (en) Combined sonic and ultrasonic skin care device
WO2004112884A3 (en) Apparatus and method for physiological treatment with electromagnetic energy
CN116139413A (en) Oxygen gradient type microneedle targeted photodynamic therapy device
ES2293334T3 (en) APPLIANCE FOR LIGHTING A MAMIFERO SKIN AREA.
KR102512824B1 (en) Skin stimulating device
WO2013172859A1 (en) Apparatus for maintaining treatment of peripheral neuropathy
EP2316405A1 (en) Apparatus for stimulation of tissues, particularly for female erogenous zones
ES2386308T3 (en) Device for the application of phototherapy
RU2241428C1 (en) Hair growth stimulating massaging comb
RU2268761C2 (en) Magnetic light therapeutic device
JP2006025808A (en) Wrinkle removing device
ITTO20120531A1 (en) DEVICE FOR TRANSDERMIC AND / OR INTRADERMAL VEHICLE
KR20150101791A (en) Apparatus for treating and promoting hair growth
ES2534528A1 (en) Light-emitting silk fiber for light (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16747171

Country of ref document: EP

Kind code of ref document: A1

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112017014275

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2017540701

Country of ref document: JP

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2016747171

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20177021793

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2017130913

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112017014275

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20170630